Enhanced Kidney Follow-up for AKI Survivors in Care Transitions

Acute Kidney Injury Clinical Trial

Official title:

Enhanced Kidney Follow-up for AKI Survivors in Care Transitions (The ACT Study): Impact on Patient Reported Outcomes

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04505891
• Other study ID #: 20-004204
• Status: Completed
• Phase: N/A
• Start date: August 17, 2020
• Est. completion date: December 21, 2021

Study information

• Verified date: January 2022
• Source: Mayo Clinic
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The purpose of this study is to assess the ability of education and outpatient kidney care follow-up in order to improve patient knowledge about acute kidney injury (AKI).

Recruitment information / eligibility

• Status: Completed
• Enrollment: 49
• Est. completion date: December 21, 2021
• Est. primary completion date: December 21, 2021
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• KDIGO Stage 3 AKI

• Primary care provider at Mayo Rochester.

Exclusion Criteria:

• Patient with need for dialysis at discharge from hospital or hospice.

• Enrolled in the Primary Care Transition Program.

• Non-English speaking.

• Cognitive impairment.

• Dementia.

• Mini-Cog score of less than 3.

Related Conditions & MeSH terms

• Acute Kidney Injury

Intervention

Behavioral:
• Education
Kidney health education will be delivered prior to discharge by trained nurse educators.
• Education and follow-up
In patients allocated to the education and follow-up arm, education along with a a post-discharge healthcare visit from a multidisciplinary care team will be performed.

Locations

Country	Name	City	State
United States	Mayo Clinic in Rochester	Rochester	Minnesota

Sponsors (1)

Lead Sponsor	Collaborator
Mayo Clinic

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Modified Kidney Knowledge Survey (mKIKS)	Assesses participants' objective knowledge about AKI causes, risk factors, and management. The minimum score is 0, maximum score is 15, higher scores indicate greater knowledge.	14-days after last study contact
Secondary	Brief health literacy screen	A 4-item tool to assess health literacy. Minimum score of 0, maximum score 20, higher scores indicate higher health literacy	30-days post hospitalization
Secondary	Patient-Reported Outcomes Measurement Information System (PROMIS) Global Health 10	Based on the provided responses, an overall summary score, and two subset scores - Global health physical and Global health mental can be calculated. Raw summed score are converted into T-scores. Higher scores indicate better health.	30-days post hospitalization

External Links

•   Mayo Clinic Clinical Trials